Research and Development

The Research and Development team at Currus Biologics focuses on innovating and advancing CAR-T cell therapies for solid tumor cancers. They conduct extensive preclinical research, optimize therapeutic protocols, and collaborate with leading experts to enhance immune response and treatment efficacy. Their goal is to translate cutting-edge scientific discoveries into safe and effective treatments for patients.